Cambridge Investment Research Advisors, Inc.
Position in BVS — Bioventus Inc.
CIK 1419186
FAIRFIELD, IA
Position in BVS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$394,096
New position
Shares Held
43,165
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $94,085,440 across 27 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
299,079 | $27,138,428 | |
| 2 | SYK |
Stryker Corp
|
73,172 | $23,037,472 | |
| 3 | MDT |
Medtronic plc
|
241,056 | $18,857,810 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
82,290 | $5,267,382 | |
| 5 | EW |
Edwards Lifesciences Corp
|
45,749 | $4,138,454 | |
| 6 | DXCM |
Dexcom Inc
|
45,009 | $3,031,356 | |
| 7 | BSX |
Boston Scientific Corp
|
51,066 | $2,179,496 | |
| 8 | STE |
STERIS plc
|
7,965 | $1,677,190 |
All Filings in BVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $394,096 | 43,165 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||